Why these developments matter

Inherited retinal diseases (IRDs) are caused by changes in genes that affect the retina, the light-sensitive tissue at the back of the eye. For people and families living with an IRD, research can advance along more than one path: scientists may uncover a previously unrecognised cause of vision problems, while clinicians test ways to address disease-causing genetic changes directly.

Two reports illustrate these complementary directions. A 2024 study highlighted by Ophthalmology Times Europe links high-frequency electrical “noise” in the retina with congenital night blindness. Separately, a 2020 report from Oregon described doctors at Oregon Health & Science University (OHSU) editing genes inside a person’s eye in an effort to reverse blindness.

Electrical signals may be part of congenital night blindness

The Ophthalmology Times Europe report describes research suggesting that unusually high-frequency electrical activity—described as “noise”—may be associated with congenital night blindness. Congenital night blindness refers to difficulty seeing in low light that is present from birth or early life. It can occur as part of an inherited retinal condition or as an isolated disorder.

The finding is important because vision depends not only on the retina’s ability to detect light, but also on how retinal cells pass signals onward through the visual system. If those signals contain excessive electrical noise, the information reaching the brain may be less clear, particularly in dim conditions where vision is already challenging.

Research that examines retinal electrical activity can help investigators better understand the biology behind symptoms. It may also contribute to more precise ways of identifying and categorising disorders that affect night vision. The report does not establish a new treatment, but it points to a potential mechanism that researchers can investigate further.

Gene editing inside the eye: an early clinical milestone

In the Oregon report, OHSU doctors were described as editing a person’s genes inside the eye as part of an effort to reverse blindness. The approach is notable because it aims to alter genetic material directly in retinal tissue rather than simply manage symptoms.

Gene editing is distinct from gene replacement, in which a working copy of a gene is delivered to cells. In principle, editing approaches seek to make a targeted change to DNA at the site of a disease-related variant. Delivering these tools to the eye is an especially active area of research because the retina can be reached locally and changes can be monitored with detailed imaging and vision tests.

The 2020 report represents an early step in the development of in-eye gene-editing research, not evidence that the approach can broadly restore vision across IRDs. Results from early studies are essential for understanding whether a technique can be delivered safely, whether it reaches the intended cells and whether it produces a meaningful effect on vision.

What this means for IRD research

Together, these reports show why progress in IRDs relies on both basic science and clinical investigation. Studies of retinal electrical signalling may reveal new disease mechanisms and identify measurements that could support diagnosis or future treatment studies. Gene-editing efforts test whether genetic discoveries can eventually be translated into therapies for specific conditions and variants.

For the IRD community, the direction of travel is encouraging: researchers are studying the retina at multiple levels, from its electrical communication networks to the DNA inside its cells. The next steps will depend on continued laboratory work, carefully designed clinical studies and long-term follow-up to determine which approaches can safely deliver lasting benefit.

Sources

  • Ophthalmology Times Europe. “Study: High-frequency electrical ‘noise’ may result in congenital night blindness.” May 21, 2024. Google News link
  • OregonLive.com. “OHSU doctors edit a person’s genes inside the eye to try to reverse blindness.” March 4, 2020. Google News link